AuntMinnie.com staff writersImaging LeadersFlywheel appoints new CEOFlywheelFlywheel.io has named Matthew A. Michela as its next CEO.October 10, 2024PACS/VNASynthesis Health signs Strategic RadiologySynthesis Health has formed a partnership with the coalition of independent radiology practices.October 9, 2024Digital X-RayAgfa expands line of DR flat panel detectorsAgfa Radiology SolutionsAgfa Radiology Solution has launched a new range of digital radiography (DR) flat panel detectors in its Dura-line family.October 9, 2024PACS/VNAGE HealthCare integrates AI from BlackfordGE HealthCareGE HealthCare has integrated the Blackford Platform into its True PACS and Centricity PACS platforms.October 9, 2024MRISpringbok gets FDA nod for AI muscle analysis technologySpringbok Analytics has secured U.S. FDA clearance for MuscleView, an AI algorithm for analyzing muscle health from MRI scans.October 9, 2024Molecular ImagingPositrigo gets CE mark for brain PET systemNuclear medicine technology firm Positrigo has secured European market clearance for its dedicated brain PET system, NeuroLF.October 8, 2024Womens ImagingOntario lowers age limit for publicly funded mammogramsWomen over the age of 40 in Ontario can now self-refer for publicly funded mammograms through the government’s breast cancer screening program.October 8, 2024UltrasoundEchoNous partners with MendaeraEchoNous and Mendaera have established a commercial partnership to develop new ultrasound-guided technology for interventional procedures.October 8, 2024AIRadpair launches Radpair 2.0Radpair has launched Radpair 2.0, the latest version of its AI-driven radiology reporting system.October 8, 2024MRIGE highlights trial results for macrocyclic manganese-based MRI agentGE HealthCareGE HealthCare (GEHC) is highlighting results from a phase I clinical trial for a macrocyclic manganese-based MRI contrast agent.October 7, 2024Previous PagePage 205 of 308Next PageTop StoriesMolecular ImagingImmuno-PET/CT detects myeloma missed by FDG-PET/CTStandard FDG PET/CT misses active multiple myeloma in 30% to 50% of patients with biopsy-proven disease.CT'ExRad' data shows wide variations in CT radiation doseWomens ImagingCEM improves margin extent measurement, falls short of primary outcomeMRIPodcast: Why 'minimum' MRI safety standards aren’t minimum enoughSponsor ContentFREE webinar: find your imaging capacity